PHARMACEUTICALS

The COVID-19 pandemic may still occupy much of the global health community's attention, but the challenges facing providers and innovators beyond the pandemic are enormous.

The healthcare industry's big data shows that cardiovascular disease is the leading cause of death anywhere in the world.

It kills more individuals than all malignancies put together.

Despite the complexity of its underlying causes, it is evident that public health systems are not suited to address the problem on a large scale

The analysis of healthcare big data influenced the decision-making of pharmaceutical industries to increase R&D investments by launching tax incentives and adopting more flexible regulatory standards for clinical trials.

This affords pharmaceutical companies opportunities to not only serve the domestic market but also to enter international markets with relatively older age groups.